Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
about
RLIP76, a non-ABC transporter, and drug resistance in epilepsy.A multi-system approach assessing the interaction of anticonvulsants with P-gpLack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled ratsMonitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Challenges and opportunities in the application of pharmacogenetics to antiepileptic drug therapy.Multidrug resistance in epilepsy: a pharmacogenomic update.The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.Epilepsy pharmacogenetics.Fexofenadine hydrochloride in the treatment of allergic disease: a reviewPotential role of multidrug resistant proteins in refractory epilepsy and antiepileptic drugs interactions.Intractable epilepsy and the P-glycoprotein hypothesis.Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy.Beneficial effect of tetrandrine on refractory epilepsy via suppressing P-glycoprotein.Marked differences in the effect of antiepileptic and cytostatic drugs on the functionality of P-glycoprotein in human and rat brain capillary endothelial cell lines.Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.Potential role for human P-glycoprotein in the transport of lacosamide.In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: a 10-week open-label study.Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.Antiepileptic drug transport--of mice and men.Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.Drug Transport at the Brain and Endothelial Dysfunction in Preeclampsia: Implications and Perspectives
P2860
Q24533543-21BBA2C2-BB58-4B7A-8B5D-682268941B68Q28533527-36BE3B11-C391-4B20-A55C-55D3297E7C39Q30361123-E95E1CB6-8B19-4EC6-8534-235972168C8AQ33772891-2B3118F2-457E-4D3F-8F95-5FFE434C9EAFQ34570859-3ABAEC42-7A6D-432F-A63F-2D66673867DAQ36157234-E6F57178-9148-4205-8571-8297FEB84DE6Q36341748-889A215A-5D8A-413A-8E67-08B4FAFBF46CQ36895830-F6C2819B-4910-4D9B-AAC8-83CDB5D4F873Q37024001-B0FAD4CF-2880-4359-979B-307C77531344Q37486720-E97846BE-FC37-49F9-9D24-3AA698687B8AQ37857671-A4E2A33F-58B1-494C-AC6C-0665168F3F01Q37873936-019F4850-32FB-48FE-B0B2-F439A1453650Q38497941-165A4624-0F44-4CCF-91B1-6E8599105FBDQ38888350-B5BA259A-2C38-4476-8F40-6F065F8F4138Q38955379-15FE71C3-867F-4139-B0D0-53170D02FAD5Q39029172-BD5D5A1B-082A-4E09-AD74-717AA4E8045CQ39164058-2F26E464-3D67-473D-812F-AAD94F716447Q39172259-743DC113-F26F-4CFE-81BA-89EE13DA1BA7Q39520772-7FBD4919-DFA3-4F83-BF9A-E3606ADAC9D6Q42130578-8A71679A-47B6-4201-8966-E77FB1A8BBF0Q42985589-E1B77C5C-87EB-4D05-887B-FC1521176F8FQ43073437-3765DFDC-458F-420F-81B6-B8A45B82333AQ46962049-9387BA54-0C64-4E66-94E9-4C825C06F404Q46984881-0687B206-02F6-44F1-B206-976F0AB0E4CDQ55055431-4926127E-BAE0-4B35-916D-730324AFE51CQ59136492-4EF00C90-8E00-4993-84BF-5C562D2A6F33
P2860
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@ast
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@en
type
label
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@ast
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@en
prefLabel
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@ast
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@en
P2093
P356
P1476
Interaction of antiepileptic drugs with human P-glycoprotein in vitro.
@en
P2093
Christian Johannes Kerpen
Heike Lindenmaier
Johanna Weiss
Sven-Maria Gregor Dormann
P304
P356
10.1124/JPET.103.054197
P407
P577
2003-09-03T00:00:00Z